GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · IEX Real-Time Price · USD
4.685
+0.205 (4.58%)
Mar 28, 2024, 12:00 PM EDT - Market open
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $6.03 million as of March 28, 2024. Its market cap has decreased by -67.21% in one year.
Market Cap
6.03M
Enterprise Value
-7.88M
1-Year Change
-67.21%
Ranking
Category
Stock Price
$4.69
Market Cap Chart
Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $6.03M, a decrease of -92.75%. That is a compound annual growth rate of -35.40%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 6.00M | -1.64% |
Mar 26, 2024 | 6.10M | - |
Mar 25, 2024 | 6.10M | -3.17% |
Mar 22, 2024 | 6.30M | 18.87% |
Mar 21, 2024 | 5.30M | -8.62% |
Mar 20, 2024 | 5.80M | -6.45% |
Mar 19, 2024 | 6.20M | 1.64% |
Mar 18, 2024 | 6.10M | -4.69% |
Mar 15, 2024 | 6.40M | -1.54% |
Mar 14, 2024 | 6.50M | 3.17% |
Mar 13, 2024 | 6.30M | -11.27% |
Mar 12, 2024 | 7.10M | 5.97% |
Mar 11, 2024 | 6.70M | 11.67% |
Mar 8, 2024 | 6.00M | -1.64% |
Mar 7, 2024 | 6.10M | 1.67% |
Mar 6, 2024 | 6.00M | 1.69% |
Mar 5, 2024 | 5.90M | -6.35% |
Mar 4, 2024 | 6.30M | 3.28% |
Mar 1, 2024 | 6.10M | 5.17% |
Feb 29, 2024 | 5.80M | - |
Feb 28, 2024 | 5.80M | 1.75% |
Feb 27, 2024 | 5.70M | 3.64% |
Feb 26, 2024 | 5.50M | 3.77% |
Feb 23, 2024 | 5.30M | -8.62% |
Feb 22, 2024 | 5.80M | 3.57% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Oragenics | 6.36M |
ZyVersa Therapeutics | 6.20M |
Universe Pharmaceuticals INC | 6.16M |
Azitra | 6.14M |
Pulmatrix | 6.10M |
Xenetic Biosciences | 6.09M |
Vivos Therapeutics | 6.06M |
Kineta | 6.05M |